SFS
ACAD icon

Sowell Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Sowell Financial Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,963
Closed -$62K – 532
2021
Q1 		$62K Buy
2,963
+348
+13% +$15.3K ﹤0.01% 1554
2020
Q4 		$140K Buy
2,615
+805
+44% +$40K 0.01% 1010
2020
Q3 		$75K Sell
1,810
-811
-31% -$35K ﹤0.01% 1078
2020
Q2 		$127K Buy
2,621
+867
+49% +$41.6K 0.01% 893
2020
Q1 		$74K Buy
1,754
+258
+17% +$10.6K 0.01% 925
2019
Q4 		$64K Buy
+1,496
New +$65.1K ﹤0.01% 1063

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return